{{Rsnum
|rsid=39317
|Chromosome=7
|position=117326250
|Orientation=plus
|GMAF=0.4261
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 19.5 | 42.5 | 38.1
| HCB | 16.8 | 47.4 | 35.8
| JPT | 12.4 | 46.0 | 41.6
| YRI | 26.5 | 50.3 | 23.1
| ASW | 24.6 | 49.1 | 26.3
| CHB | 16.8 | 47.4 | 35.8
| CHD | 15.7 | 59.3 | 25.0
| GIH | 28.7 | 49.5 | 21.8
| LWK | 39.1 | 47.3 | 13.6
| MEX | 24.1 | 36.2 | 39.7
| MKK | 43.6 | 47.4 | 9.0
| TSI | 10.8 | 48.0 | 41.2
| HapMapRevision=28
}}SNP [[rs39317]] has been associated with both cholesterol levels and low-density lipoprotein levels in the Framingham Heart Study datasets, and is thus associated with [[heart disease]]. [http://gmed.bu.edu/about/analysis.html source]

{{PMID Auto
|PMID=17903304
|Title=Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}